First, the activation status and virulence potential of CD8+ T cells were highly specific in kidney cancer, where stem-like TCF1+ or PD-1+ TIM3− LAG3− CD8 + T cell subsets contribute to the anti-cancer immune effect [30–32]. Here, CD8A is linked to kidney cancer.